PTPRC and neoplasm: The spiked-in blood samples obtained were processed with the CellSearch® platform, undergoing an EPCAM-based enrichment step, followed by the evaluation of the enriched cells for the expression of CK (tumor identification marker), CD45 (negative selection marker) and HER2 (characterization marker).